Erin McCreary

Dr. McCreary’s primary research interests focus on a “bench to bedside” approach of optimizing pharmacokinetic and pharmacodynamic principles for antimicrobial utilization and translational antibiotic stewardship initiatives. In less than 18 months at UPMC, she led and implemented stewardship initiatives including: dose-optimization of anti-pseudomonal beta-lactam antibiotics, comprehensive antimicrobial dosing chart by indication, transplant prophylaxis guideline updates, novel necrotizing skin and soft tissue infection pathway, evaluation and assessment of beta-lactam allergy pathway, vancomycin area-under-the-curve-based dosing pharmacokinetic service, and antifungal stewardship.

Dr. McCreary is a pharmacist who serves as the Chair of the UPMC System COVID-19 Therapeutics Committee. She also engages in tele-stewardship with several communities hospitals and rounds with the Presbyterian Shadyside infectious diseases consult services. She specializes in the management of patients infected by drug-resistant and/or fungal pathogens.